PO.TB10.06 · 肿瘤生物学
使用多重免疫荧光技术研究微卫星稳定与不稳定胃癌中肿瘤相关中性粒细胞密度及癌细胞相互作用
Tumor-associated neutrophil density and cancer cell interaction in microsatellite stable and unstable gastric cancer using multiplex immunofluorescence
该海报暂无可下载的资料
AACR 官方页面
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
目的:肿瘤相关中性粒细胞(TANs)在肿瘤微环境中发挥多样化作用,但其在胃癌(GC)中的临床病理学和预后意义,尤其是活化 TAN 亚群及其与肿瘤细胞的空间相互作用的相关性,仍不明确。本研究旨在表征 TAN 密度、活化状态及其与肿瘤细胞的空间邻近性,重点关注微卫星高度不稳定(MSI-H)胃癌。
方法:对 1,060 例胃癌进行了 CD66b、CD8、HER2、p53 和 E-cadherin 的单一免疫组织化学(sIHC),同时进行 MSI 检测和 EB 病毒(EBV)原位杂交。为探索 TAN 相关生存中潜在的性别差异,另外进行了 ER sIHC。为定义功能性 TAN 亚群,对 59 例微卫星稳定(MSS)和 60 例 MSI-H 病例进行了针对细胞角蛋白(CK)、CD66b 和 CD177 的 Opal 多重免疫荧光(mIF)。使用 QuPath(sIHC)和 InForm(mIF)对免疫细胞密度进行定量。计算了 TANs 与 CK+ 肿瘤细胞之间的空间邻近性。通过 Kaplan-Meier 分析评估生存。
结果:sIHC 上高密度的 CD66b+ TANs 更常见于肠型胃癌和较低的 pT 分期(P<0.001)。较高的 TAN 密度与 HER2 阳性、膜性 E-cadherin 表达、EBV 阳性和 MSI-H 表型相关(P<0.001)。在肿瘤中心与浸润边缘之间的 TAN 密度中发现中度相关。高密度 CD66b+ TANs 的患者倾向于具有更好的总生存(OS),而对中心和浸润边缘 TAN 密度的联合分析表明其为独立预后因素(P=0.036)。在亚组分析中,较高的 TAN 密度与女性患者改善的 OS 相关(p<0.001)。通过 mIF,CD66b+ TANs 和 CD66b+/CD177+ 活化 TANs 的密度在 MSI-H 中显著高于 MSS 胃癌(p<0.01)。从胃癌细胞到最近的 CD66b+ TAN 或 CD66b+/CD177+ 活化 TAN 的距离在 MSI-H 胃癌中显著更短(p<0.001)。TAN 密度在邻近肿瘤细胞的区域较高,而在较远区域较低,MSI-H 胃癌中的梯度更为明显。较短的 TAN-肿瘤距离与更好的生存相关。特别是,活化 CD66b+/CD177+ TANs 与肿瘤细胞更近的邻近性独立地与改善的 OS 相关(p=0.041)。
结论:TANs 与胃癌细胞之间的距离在 MSI-H 肿瘤中显著更短,而较短的 TAN-肿瘤距离——尤其是对于活化的 CD66b+/CD177+ TANs——与更好的总生存相关。这些发现凸显了 TAN-肿瘤空间邻近性作为关键预后因素以及作为胃癌未来治疗策略潜在靶点的意义。
查看英文原文 English abstract
Purpose: Tumor-associated neutrophils (TANs) play diverse roles in the tumor microenvironment, yet their clinicopathologic and prognostic significance in gastric cancer (GC), particularly the relevance of activated TAN subsets and their spatial interactions with tumor cells, remains unclear. This study aimed to characterize TAN density, activation status, and spatial proximity to tumor cells, with focus on microsatellite instability-high (MSI-H) GC.
Methods: Single immunohistochemistry (sIHC) for CD66b, CD8, HER2, p53 and E-cadherin was performed in 1,060 GCs, together with MSI testing and Epstein-Barr virus (EBV) in situ hybridization. To explore potential sex-related differences in TAN-associated survival, ER sIHC was additionally performed. To define functional TAN subsets, Opal multiplex immunofluorescence (mIF) for cytokeratin (CK), CD66b, and CD177 was conducted in 59 microsatellite-stable (MSS) and 60 MSI-H cases. Immune cell densities were quantified using QuPath (sIHC) and InForm (mIF). Spatial proximity between TANs and CK+ tumor cells was calculated. Survival was assessed by Kaplan-Meier analysis.
Results: A high density of CD66b+ TANs on sIHC was more frequently observed in intestinal-type GC and at lower pT stages ( P <0.001). A higher TAN density was correlated with HER2 positivity, membranous E-cadherin expression, EBV positivity, and the MSI-H phenotype ( P <0.001). A moderate correlation was found in TAN densities between the tumor center and invasive margin. Patients with a high density of CD66b+ TANs tended to have better overall survival (OS), and combined analysis of central and invasive margin TAN densities indicated an independent prognostic factor ( P =0.036). In subgroup analysis, higher TAN density was associated with improved OS in female patients ( p <0.001). By mIF, the densities of CD66b+ TANs and CD66b+/CD177+ activated TANs were significantly higher in MSI-H than MSS GC ( p <0.01). The distance from GC cell to the nearest CD66b+ TAN or CD66b+/CD177+ activated TAN was significantly shorter in MSI-H GC ( p <0.001). TAN density was higher in
areas adjacent to tumor cells and lower in distant regions, with a more pronounced gradient in MSI-H GC. A shorter TAN-tumor distance was associated with better survival. In particular, closer proximity of activated CD66b+/CD177+ TANs to tumor cells was independently associated with improved OS ( p =0.041).
Conclusions: The distance between TANs and GC cells was significantly shorter in MSI-H tumors, and a shorter TAN-tumor distance-especially for activated CD66b+/CD177+ TANs-was associated with better overall survival. These findings highlight TAN-tumor spatial proximity as a key prognostic factor and a potential target for future therapeutic strategies in GC.
利益披露 Disclosure
S. Nam, None..
S. Yu, None..
S. Ahn, None..
Y. Park, None..
Y. Kwak, None..
S. Oh, None..
K. Park, None..
H. Lee, None.